Showing results (11-20 of 94) with videos related to
Sort By:
Pageof 10
Biotechnology Progress|June 2, 2001
Programmed Escherichia coli cell lysis by expression of cloned T4 phage lysis genesM Morita, K Asami, Y Tanji, et al.Gene|August 5, 1994
Identification of the domain required for trans-cleavage activity of hepatitis C viral serine proteinaseY Tanji, M Hijikata, Y Hirowatari, et al.Applied Microbiology and Biotechnology|August 6, 2013
Identification of crude-oil components and microorganisms that cause souring under anaerobic conditionsR Hasegawa, K Toyama, K Miyanaga, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1987
[Adoptive immunotherapy of malignant diseases with LAK cells]Y Kimoto, Y Tanji, T Tanaka, et al.Journal of Bacteriology|March 1, 1991
Effect of OmpA signal peptide mutations on OmpA secretion, synthesis, and assemblyY Tanji, J Gennity, S Pollitt, et al.FEMS Microbiology Letters|November 5, 1999
Evidence for a novel Chlorella virus-encoded alginate lyaseK Suda, Y Tanji, K Hori, et al.Applied Microbiology and Biotechnology|January 5, 2006
The survival response of Escherichia coli K12 in a natural environmentS H Na, K Miyanaga, H Unno, et al.Applied Microbiology and Biotechnology|March 6, 2002
Fungal contribution to in situ biodegradation of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) film in soilB I Sang, K Hori, Y Tanji, et al.Journal of Bioscience and Bioengineering|October 20, 2005
Enhanced microbial adaptation to p-nitrophenol using activated sludge retained in porous carrier particles and simultaneous removal of nitrite released from degradation of p-nitrophenolX H Xing, T Inoue, Y Tanji, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Use of human leukocyte antigen-mismatched allogeneic lymphokine-activated killer cells and interleukin-2 in the adoptive immunotherapy of patients with malignanciesY Kimoto, T Tanaka, Y Tanji, et al.Pageof 10